UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000002079
Receipt No. R000002529
Scientific Title Multi-center open labeled trial on effects of candesartan on heart rate and blood pressure in the early morning in patients with hypertension
Date of disclosure of the study information 2009/07/01
Last modified on 2018/10/31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multi-center open labeled trial on effects of candesartan on heart rate and blood pressure in the early morning in patients with hypertension
Acronym Domestic Observation of Heart Rate and Systemic Arterial Blood Pressure in the Morning (DOHSAM study-1)
Scientific Title Multi-center open labeled trial on effects of candesartan on heart rate and blood pressure in the early morning in patients with hypertension
Scientific Title:Acronym Domestic Observation of Heart Rate and Systemic Arterial Blood Pressure in the Morning (DOHSAM study-1)
Region
Japan

Condition
Condition Hypertension
Classification by specialty
Medicine in general Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim is to compare the effect of candesartan and other ARBs on heart rate and blood pressure in the early morning in patients with hypertension.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Home blood pressure and heart rate in the early morning
Ratio of morning and evening blood pressure (M/E ratio)
Key secondary outcomes Seasonal change in blood pressure

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 In patients with hypertension treating with ARBs other than candesartan with blood pressure more than 135/85 mmHg, we will change ARBs to candesartan and follow up for 1 year.
When we change ARBs to candesartan , we regard that candesartan 4mg corresponds to losartan 25mg, valsartan 40mg, telmisartan 20mg and olmesartan 10mg, respectively. Maximal dose of each ARB corresponds to candesartan 12mg.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Hypertensive patients with home blood pressure more than 135/85 mmHg in the early morning.
Key exclusion criteria 1)Patient with allergy to candesartan or amlodipine
2)Pregnant woman or possible pregnant woman
3)Patients with maximal dose of candesartan or amlodipine
4)Patients receiving Ca channel blockers other than amlodipine
5)Patients with atrial fibrillation or its past history
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Shinya Minatoguchi
Organization Gifu university graduate school of medicine
Division name Cardiology
Zip code
Address Yanagido 1-1, Gifu city
TEL 058-230-6520
Email minatos@gifu-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Shinya Minatoguchi
Organization Gifu university graduate school of medicine
Division name Cardiology
Zip code
Address Yanagido1-1
TEL 058-230-6520
Homepage URL
Email minatos@gifu-u.ac.jp

Sponsor
Institute Gifu university graduate school of medicine, department of cardiology
Institute
Department

Funding Source
Organization Gifu university graduate school of medicine
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2009 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2008 Year 08 Month 05 Day
Date of IRB
Anticipated trial start date
2008 Year 09 Month 01 Day
Last follow-up date
2010 Year 09 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2009 Year 06 Month 16 Day
Last modified on
2018 Year 10 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002529

Research Plan
Registered date File name
2017/12/22 Candesaratn論文.pdf

Research case data specifications
Registered date File name
2017/12/22 Candesaratn論文.pdf

Research case data
Registered date File name
2017/12/22 Candesaratn論文.pdf


Contact us.